Clinical Trial

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 21, 2020 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This study suggested that hydrogen has a potential as an effective and safe therapeutic agent on cGVHD.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2016-09-27; most recent amendment 2020-07-17.
Trial Details
NCT Number NCT02918188
Lead Sponsor Navy General Hospital, Beijing
Conditions Chronic Graft-versus-host Disease
Enrollment 21 participants
Start Date 2016-01
Primary Completion 2026-01 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2020-07-21